UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000021337
Receipt No. R000024339
Official scientific title of the study Safety and efficacy of scallop-plasmalogen on patients with primary insomnia:double-blind crossover trial with Polysomnography
Date of disclosure of the study information 2016/03/04
Last modified on 2017/09/06 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Safety and efficacy of scallop-plasmalogen on patients with primary insomnia:double-blind crossover trial with Polysomnography
Title of the study (Brief title) Safety and efficacy of scallop-plasmalogen on patients with primary insomnia
Region
Japan

Condition
Condition primary insomnia
Classification by specialty
Medicine in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To polysomnographically evaluate the effects of improving sleep quality in patients with insomnia by scallop-plasmalogen intake
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Improvement of wake after sleep onset
Key secondary outcomes Improvement of sleep efficiency and sleep latency

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Stage 1
Test food containing 0.5 mg scallop-plasmalogen administered, twice a day for 2 weeks
Stage 2
Placebo administered, twice a day for 2 weeks
Interventions/Control_2 Stage 1
Placebo administered, twice a day for 2 weeks
Stage 2
Test food containing 0.5 mg scallop-plasmalogen administered, twice a day for 2 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
25 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria 1.Informed consent from patients or proxies
2.Male or female patients aged 25 through 65 years with primary insomnia involving hypnagogic disorder or awakening that lasts for more than three months
3.Patients who are not taking sleeping medicine continuously or are able to stop taking one-shot-medicine within 14 days of starting examination
4.Patients judged eligible for this study by the investigator
Key exclusion criteria 1.Patients with depression, history of severe mental or physical illness, or sleep disorder other than insomnia (sleep apnea syndrome, restless legs syndrome)
2.Patients with scallop allergy
3.Patients judged ineligible for this study by the investigator
Target sample size 16

Research contact person
Name of lead principal investigator Kazuyuki Saito
Organization BOOCS Clinic Fukuoka
Division name Hospital director
Address 6-18 Tenya-machi, Hakata-ku, Fukuoka
TEL 092-283-6852
Email saito@tkz.bbiq.jp

Public contact
Name of contact person Kyoko Tsuchihashi
Organization BOOCS Clinic Fukuoka
Division name general affairs division
Address 6-18 Tenya-machi, Hakata-ku, Fukuoka
TEL 092-283-6852
Homepage URL
Email kyoko@boocsclinic.com

Sponsor
Institute BOOCS Clinic Fukuoka
Institute
Department

Funding Source
Organization Japanese Plasmalogen Society
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 03 Month 04 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2016 Year 02 Month 18 Day
Anticipated trial start date
2016 Year 03 Month 04 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 03 Month 04 Day
Last modified on
2017 Year 09 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024339